Long-term tralokinumab therapy in moderate to severe atopic dermatitis

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE DERMATOLOGIE | 2023年 / 49卷 / 03期
关键词：
D O I：
10.1055/a-1974-5392
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
  • [2] Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Peris, Ketty
    Katoh, Norito
    Tauber, Marie
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 30 - 31
  • [3] Long-Term Improvement in Patients with moderate to severe atopic Dermatitis treated with Tralokinumab: An ECZTEND Interim Analysis
    Beissert, Stefan
    Blauvelt, Andrew
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Herranz, Pedro
    Pink, Andrew
    Peris, Ketty
    Fangel, Stine
    Saeki, Hidehisa
    Wollenberg, Andreas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 29 - 30
  • [4] Long-term safety and efficacy of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: an interim analysis of ECZTEND
    Simpson, Eric
    Paller, Amy
    Wollenberg, Andreas
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Almgren, Peter
    Carlsson, Anna
    Blauvelt, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB190 - AB190
  • [5] Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Atopic Dermatitis in Childhood
    Oh, J.
    Kim, J.
    Baik, H.
    Lee, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB36 - AB36
  • [6] Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis
    Jee, Sue-Jung
    Kim, Joo-Hwa
    Baek, Hey-Sung
    Lee, Ha-Baik
    Oh, Jae-Won
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2011, 3 (02) : 89 - 95
  • [7] Long-term improvements observed in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: an ECZTEND interim analysis
    Blauvelt, A.
    Lacour, J. -P.
    Toth, D.
    Laquer, V.
    Beissert, S.
    Wollenberg, A.
    Herranz, P.
    Pink, A.
    Peris, K.
    Fangel, S.
    Saeki, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E112 - E113
  • [8] Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control
    Blauvelt, Andrew
    Langley, Richard G.
    Peris, Ketty
    Silvestre, Juan Francisco
    Katoh, Norito
    Tauber, Marie
    Pinter, Andreas
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II48 - II49
  • [9] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    ALLERGY, 2019, 74 : 182 - 182
  • [10] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
12345